ISOLOGIC makes $29.9 million investment in advanced isotope production facility in Quebec

2024-06-04T14:15:26-04:00June 4th, 2024|

Montreal, June 4, 2024 – ISOLOGIC Innovative Radiopharmaceuticals is investing $29.9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope supply chain as part of Quebec's life sciences ecosystem. Approximately $19 million will be devoted to the expansion [...]

Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer

2023-03-17T08:33:50-04:00March 16th, 2023|

Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men. "Health Canada has [...]

Telix and Isologic sign License and Distribution Agreement for Illuccix® for Canada

2022-11-27T14:04:02-05:00June 22nd, 2022|

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market. Please follow the link [...]

CPDC, New acquisition

2022-11-27T14:05:45-05:00December 1st, 2020|

Dear customers, We are pleased to announce that Isologic has just completed the acquisition of the FDG Canadian distribution business from Centre for Probe Development and Commercialization (CPDC). As a result, all FDG customers serviced by CPDC are, effective December 1st, serviced by Isologic out of our Toronto (Sunnybrook) facility. It has been Isologic corporate [...]

NEW PRODUCT AVAILABLE

2022-11-27T14:05:54-05:00January 9th, 2020|

Antimony Sulfide Colloid Tc99m injection January 9th, 2020 Dear Valued Customer, It is with great pleasure that we would like to inform you that Isologic has a new product within its portfolio. We are introducing Antimony Sulfide Colloid Tc99m injection. This product is indicated for use as an agent for lymphoscintigraphy and [...]

I-131 Update June 27, 2019

2022-11-27T14:06:02-05:00June 27th, 2019|

I-131 capsule and solution production update June 27th, 2019 Dear Valued Customer, We have been informed by our supplier that the last shipment of Sodium Iodide I-131 products (Therapeutics and Diagnostics) to the Canadian market will be June 26th and no production will occur until July 11th. Our supply of Sodium Iodide [...]

I-131 production update

2022-11-27T14:06:08-05:00June 12th, 2019|

Iodine-131 Diagnostic and Therapeutic capsule production June 7th, 2019 Dear Customer, We would like to inform you that we received information from our vendor of I-131 that their supplier will be in maintenance for a period of 2 weeks starting June 17th. They are working closely with another vendor to minimize the [...]

Invitation

2022-11-27T14:04:02-05:00May 30th, 2019|

Invitation Special invitation, Monday June 24, 2019 As part of the SNMMI annual conference to be held from June 22 to June 25, ISOLOGIC invites you to a seminar dedicated to innovative radiopharmaceutical services and the production of PET imaging agents. ****First come first serve**** View invitation [...]

Go to Top